Screening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 5, 2011, Pages 880-886

  Vargas, S ^a   Ndjoko Ioset, K ^a   Hay, A E ^b,c   Ioset, J R ^a   Wittlin, S ^d,e   Hostettmann, K ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITÉ LYON 1   (France)

^c University of Lyon   (France)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Hematin assay; Malaria; Plant extracts; Screening; Targeted isolation

Indexed keywords

ANTIMALARIAL AGENT; BETA HEMATIN; CARDENOLIDE DERIVATIVE; COUMARIN DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID GLYCOSIDE; FLAVONOL DERIVATIVE; HEMATIN; IRIDOID; ISOQUINOLINE ALKALOID; PHYTOSTEROL; PLANT EXTRACT; QUINONE DERIVATIVE; TANNIN DERIVATIVE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; COLORIMETRY; DRUG DETERMINATION; DRUG INHIBITION; DRUG SCREENING; GROWTH INHIBITION; MALARIA; MEDICINAL PLANT; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; ANTIMALARIALS; HEMEPROTEINS; PLANT EXTRACTS; PLANTS, MEDICINAL; PLASMODIUM; SOLID PHASE EXTRACTION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 80052790948     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.06.026     Document Type: Article

References (41)

1. World Health Organization, World malaria report 2009.
2. Marsh K. Malaria disaster in Africa. Lancet 1998, 352:352-924.
3. World Health Organization, Global report on antimalarial drug efficacy and drug resistance: 2000-2010.
4. White N.J. Antimalarial drug resistance. J. Clin. Invest. 2004, 113:1084-1092.
5. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Lwin J.T.K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P.J., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
6. Yeung S., Van Damme W., Socheat D., White N.J., Mills A. Cost of increasing access to artemisinin combination therapy: the Cambodian experience. Malar. J. 2008, 84-92.
7. Francis S.E., Sullivan D.J., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Ann. Rev. Microbiol. 1997, 51:97-123.
8. Kumar S., Guha M., Choubey V., Maity P., Bandyopadhyay U. Antimalarial drugs Inhibiting hemozoin ([β]-hematin) formation: a mechanistic update. Life Sci. 2007, 80:813-828.
9. Ziegler J., Linck R., Wright D.W. Heme aggregation inhibitors: antimalarial drugs targeting an essential biomineralization process. Curr. Med. Chem. 2001, 8:171-189.
10. Slater A.F.G., Cerami .A. Nature 1992, 355:167-169.
11. Egan T.J. Haemozoin formation. Mol. Biochem. Parasitol. 2008, 157:127-136.
12. Metgzer W.G., Mordmuller B.G., Kremsner P.G. Malaria pigment in leucocytes. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:637-638.
13. Phu N.H., Day N., Diep P.T., Ferguson D.J.P., White N.J. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:200-2004.
14. Wernsdorfer W.H., McGregor I. Malaria: Principles and Practice of Malariology 1988, Churchill-Livingstone, Edinburgh.
15. Dorn A., Vippagunta S.R., Matile H., Jaquet C., Vennerstrom J.L., Ridley R.G. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarial. Biochem. Pharm. 1998, 55:727-736.
16. Egan T.J. Haemozoin (malaria pigment): a unique crystalline drug target. Targets 2003, 115-124.
17. Sullivan D., Gluzman I.Y., Russell D.G., Goldberg D.E. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11865-11870.
18. Dorn A., Stoffel R., Matile H., Bubendorf A., Ridley R.G. Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 1995, 374:269-271.
19. Egan T.J., Ross D.C., Adams P.A. Quinoline anti-malarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett. 1994, 54-57.
20. Basilico N., Pagani E., Monti D., Olliaro P., Taramelli D. A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J. Antimicrob. Chemother. 1998, 55-60.
21. Pandey A.V., Singh N., Tekwani B.L., Puri S.K., Chauhan V.S. Assay of [β]-hematin formation by malaria parasite. J. Pharm. Biomed. Anal. 1999, 20:203-207.
22. Tripathi A.K., Gupta A., Garg S.K., Tekwani B. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii an other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarial. Life Sci. 2001, 69:2725-2733.
23. Parapini S., Basilico N., Pasini E. Standardization of the physicochemical parameters to assess in vitro the β-hematin inhibitory activity of antimalarial drugs. Exp. Parasitol. 2000, 249-256.
24. Egan T.J., Mavuso W.W., Ncokazi K.K. The mechanism of β-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes. Biochemistry 2001, 40:204-213.
25. Tripathi A.K., Khan S.I., Walker L., Tekwani B.L. Spectrophotometric determination of de novo hemozoin/[β]-hematin formation in an in vitro assay. Anal. Biochem. 2004, 325:85-91.
26. Huy N.T., Uyen D.T., Maeda A. Simple colorimetric inhibition assay of heme crystallization for high throughput screening of antimalarial compounds. Antimicrob. Agents Chemother. 2007, 350-353.
27. Kurosawa Y., Dorn A., Kitsuji-Shirane M., Shimada H., Satoh T., Matile H., Hofheinz W., Masciadri R., Kansy M., Ridley R.G. Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob. Agents Chemother. 2000, 44:2638-2644.
28. Deharo E., Garcia R.N., Oporto P. A non-radiolabelled ferriprotoporphyrin IX biomineralisation inhibition test for the high throughput screening of antimalarial compounds. Exp. Parasitol. 2002, 252-256.
29. Egan T.J., Ncokazi K.K. Quinoline antimalarials decrease the rate of [β]-hematin formation. J. Inorg. Biochem. 2005, 99:1532-1539.
30. Ncokazi K.K., Egan T.J. A colorimetric high-throughput [β]-hematin inhibition screening assay for use in the search for antimalarial compounds. Anal. Biochem. 2005, 338:306-319.
31. Chong C.R., Sullivan D.J. Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem. Pharm. 2003, 66:2201-2212.
32. Sullivan D.J. Theories on malarial pigment formation and quinoline action. Int. J. Parasitol. 2002, 32:1645-1653.
33. Rush M.A., Baniecki M.L., Mazitchek R., et al. Colorimetric high-throughput screen for detection of heme crystallization inhibitors. Antimicrob. Agents Chemother. 2009, 53:2564-2568.
34. Carter M.D., Phelan V.V., Sandlin R.D., et al. Lipophilic mediated assays for β-hematin inhibitors. Comb. Chem. High Throughput Screen 2010, 13:285-292.
35. Desjardins R.E., Canfield C.J., Haynes J.D., Chulay J.D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 1979, 16:710-718.
36. Ganapaty S., Steve Thomas P., Karagianis G., Waterman G.P., Brun R. Antiprotozoal and cytotoxic naphthalene derivatives from Diospyros assimilis. Phytochemistry 2006, 67:1950-1956.
37. Egan T.J. Physico-chemical aspects of hemozoin (malaria pigment) structure and formation. J. Inorg. Biochem. 2002, 91:16-26.
38. Tasdemir D., Kaiser M., Brun R., Yardley V., Schmidt T.J., Tosun F., Ruedi P. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues. In vitro, in vivo, structure activity relationship and quantitative structure activity relationship studies. Antimicrob. Agents Chemother. 2006, 49:1352-1364.
39. Egan T.J., Hunter R., Kaschula C.H., Marques H.M., Misplon A., Walden J.C. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of hematin formation, and antiplasmodial activity. J. Med. Chem. 2000, 43:283-291.
40. de Villiers K.A, Egan T.J. Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis. Molecules 2009, 14:2868-2887.
41. Chen M.M., Shi L., Sullivan D.J. Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and β-hematin. Mol. Biochem. Parasitol. 2001, 1-8.